The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...

At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical tria ...

Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path ...

Inflammation is linked to the development of psychiatric illness. Recently, data has emerged on the usefulness of treating ...

Supernus Pharmaceuticals has said its candidate SPN-820, demonstrated a “rapid and substantial” effect in a Phase IIa trial ...

If you are experiencing depression, and considering treatment, know that it is possible to save your mood without killing ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an ...

Supernus Pharmaceuticals has linked its mTORC1 activator to rapid improvements in adults with major depressive disorder in a ...

SNRIs are often preferred for treating more severe cases of depression. Common examples include duloxetine, desvenlafaxine ...

A device that delivers a small electrical current to the brain has beneficial effects in cases of depression that doesn't ...

(A ketamine-derived drug called esketamine is approved for some people as part of treatment-resistant depression in a certified clinical setting.) But doctors have developed a protocol for ...

There was nothing else to do, so I was like, 'oh, I'll just go and do it, why not?'' It was once considered a 'dirty' drug ...